Tris Pharma Announces Positive Results From Alleviate-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-Nmr Agonist, for the Treatment of Moderate-to-Severe Acute Pain

Goldman Sachs CEO David Solomon Says the Equity Markets Exhibit a Sense of Optimism at the Moment

Goldman Sachs CEO David Solomon Says I Think It's Hard to Dispute the Fact That Equity Multiples Are High - CNBC